Stay updated on Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision metadata updated from v3.5.3 to v3.5.4, signaling a new release of the page content. This update reflects a version change rather than a substantive modification to the study details or functionality.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page’s footer revision label has been updated from v3.5.2 to v3.5.3, indicating a site software/version release rather than a change to the clinical trial information.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check113 days agoChange DetectedAdded a link to the Genetic and Rare Diseases Information Center as a resource and included the 'Gastric cancer' term; removed the funding-status notice and an older revision note.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.